SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending as investors discuss revenue growth, recent acquisitions, and potential government contracts, especially in the drone and counter-UAS sectors. While some are optimistic about the company's future and potential short squeeze, others express concerns about dilution and profitability given the current market capitalization. The community is closely watching upcoming earnings and guidance for further direction.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI CRYPTO is trending as the community rallies around the idea of shared success and financial freedom, despite some skepticism. The project's association with MMA and promotion of a 'slap' mentality against market bears is also fueling the conversation. Discussions revolve around community strength and 'diamond hands' amidst a volatile crypto market.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses potential price movements and key levels to watch. Team SLAP's activities and partnerships are generating buzz, while some traders express frustration with recent market volatility. The reopening of the government and its potential impact on the crypto market is also a point of discussion.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

SLAP is trending as the community rallies around its unique approach to crypto, highlighted by IRL partnerships and a focus on onboarding new users. Discussions center on the project's real-world utility and its sponsored MMA fighter, Karolina Arm, who embodies the 'SLAP' ethos. The community emphasizes its commitment to building and adding value to the crypto space beyond just memes.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the idea of "OG Memes" and internet culture. Community members express strong conviction, referring to themselves as a "cult" and emphasizing the project's focus on community-driven growth. The broader discussion highlights a desire to return to the roots of meme culture and internet humor.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as community members rally around the idea of overcoming financial hardship and "breaking the system." Recent catalysts include community contests and mentions in articles. The community is actively discussing potential moonshots and celebrating the project's resilience.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending following mixed Q4 earnings, with revenue slightly missing estimates but EPS exceeding expectations. The community is focused on the company's plans to increase its dividend and double its share buyback program, alongside discussions around streaming growth versus legacy TV declines. Community sentiment appears mixed, with some criticizing the company's content strategy.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending as investors are closely watching for potential movement following recent earnings and ahead of Singles Day data, with community discussions focusing on its valuation relative to peers and the impact of its expansion into new initiatives like food delivery. Some traders express frustration with the stock's performance despite positive metrics, while others see long-term potential tied to AI and robotics. There is also concern about the high number of call options and whether shareholders will profit.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave's stock is experiencing volatility following earnings, with community discussions focused on the CEO's performance and concerns about future growth. Despite a large revenue backlog, investors are reacting negatively to factors like rising costs and delayed data center buildouts. Some traders believe it is oversold and are looking for a bounce, while others are betting against it, citing high leverage and execution risks.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the crypto community anticipates the launch of the first U.S. spot XRP ETF (XRPC) on the Nasdaq, with discussions focusing on potential institutional inflows and market impact. Community members are debating whether this event is already priced in, while others discuss potential supply shock due to limited XRP available on exchanges. Broader market factors, such as government actions and correlation with Bitcoin, are also being closely monitored.

statis crypto Watchlist

Bitcoin

Ethereum

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MRSN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Mersana Therapeutics, Inc. is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Mersana Therapeutics, Inc. (NASDAQ: MRSN) to Day One Biopharmaceuticals, Inc. is fair to Mersana shareholders...

Mersana Therapeutics To Be Acquired By Day One Biopharmaceuticals For Up To $285 Mln

(RTTNews) - Mersana Therapeutics, Inc. (MRSN), a biopharmaceutical company, Thursday, announced that it has entered a definitive agreement to be acquired by Day One Biopharmaceuticals through a...

<ul class="summary-bullets"><li>Day One will purchase Mersana for a total consideration of up to $55.25 per share.&nbsp;</li><li>The transaction is expected to close by the end of January 2026, and Day One expects to finance it with existing cash resources.&nbsp;</li><li>The acquisition will add antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le) to Day One’s cancer portfolio.</li></ul>Day One Biopharmaceuticals, Inc. (DAWN) said on Thursday that it has signed a definitive merger agreement to acquire Mersana Therapeutics (MRSN) for up to $285 million to expand its oncology portfolio.Brisbane-based Day One will commence a tender offer to acquire all of the outstanding shares of Mersana common stock for $25 per share in cash at closing, in addition to a contingent value right that allows holders to receive up to an aggregate of $30.25 per CVR upon the completion of certain milestones for a total consideration of up to $55.25 per share.The upfront purchase price of $25 alone represents a premium of 182% from Mersana’s closing price on Wednesday. The transaction is expected to close by the end of January 2026, and Day One <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/13/3187097/0/en/Day-One-to-Acquire-Mersana-Therapeutics-to-Advance-Mission-to-Bring-New-Medicines-to-People-of-All-Ages-with-Life-Threatening-Diseases.html">expects</a> to finance it with existing cash resources.<a href="https://stocktwits.com/symbol/MRSN">MRSN shares</a> traded 200% higher in the pre-market session at the time of writing while <a href="https://stocktwits.com/symbol/DAWN">DAWN shares</a> dropped 12%.<h2 class="st-heading-2">Expanding Its Oncology Portfolio</h2>The acquisition will add antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le) to Day One’s cancer portfolio. Emi-Le has demonstrated early anti-tumor activity in an ongoing early-stage study for an aggressive cancer called adenoid cystic carcinoma type-1.Day One believes that Emi-Le is well-positioned for potential rapid development and commercialization and expects its financial profile to aid the development of it through potential approval with no additional financing.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around MRSN jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.MRSN stock is down by 75% this year and by 87% over the past 12 months. Meanwhile, DAWN stock has lost 18% this year.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ford-gears-up-for-wider-bluecruise-rollout-across-europe-in-2026/cLP9TrNRE3g">Ford Gears Up For Wider BlueCruise Rollout Across Europe In 2026</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal

The upfront purchase price of $25 alone represents a premium of 182% from Mersana’s closing price on Wednesday.

Equity

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates

Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.00% and -14.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Curis (CRIS) Reports Q3 Loss, Beats Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of +20.97% and +8.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Royalty Pharma (RPRX) Beats Q3 Earnings and Revenue Estimates

Royalty Pharma (RPRX) delivered earnings and revenue surprises of +5.41% and +1.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Analysts See a 314.81% Upside in Mersana Therapeutics (MRSN): Can the Stock Really Move This High?

The mean of analysts' price targets for Mersana Therapeutics (MRSN) points to a 314.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 248.8% in Mersana Therapeutics (MRSN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Lags Revenue Estimates

Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of -8.80% and -58.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of +29.82% and +181.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.

Mersana Therapeutics Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$27.28
Prev Close	$8.91
Open	$8.70
Dividend Yield	0.00%
50-Day Moving Average	$8.51
Beta	2.06
Avg. Volume	64,039.48
PE Ratio	-0.59

52-Week High	$70.73
52-Week Low	$5.21
Market Capitalization	$44.27M
EPS (Annual)	-$14.12
Price to Book	-0.83
Revenue Per Employee	$397,029.41
Enterprise Value/EBITDA	N/A

MRSN
Mersana Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRSN News

MRSNMersana Therapeutics Inc